Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer’s dementia nod without extra studies fkansteiner Tue, […]

AbbVie, after losing Humira trade secrets theft case, eyes new strategy in Alvotech fight fkansteiner Tue, 12/21/2021 – […]

Reliable and feasible early detection of Alzheimer’s disease is the goal of DEBBIE, an international joint project under […]

Scientists at the Universidad Carlos III de Madrid have developed the first photo-electrochemical aptasensor that detects the SARS-CoV-2 […]

In 2017, we described the previous UK drug strategy as full of “false claims and empty promises.”1 The […]

AbstractObjectiveTo evaluate pathological complete response as a surrogate endpoint for disease-free survival and overall survival in regulatory neoadjuvant […]

The DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types […]

With approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten […]

It was a step too far for ninety nine Conservative MPs. They were simply unwilling to support the […]

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring […]